PAR paradigm biopharmaceuticals limited..

The P Value Primer, page-8

  1. 209 Posts.
    lightbulb Created with Sketch. 28
    Thanks for your post Mozz. Not sure if my understanding is right here. Do you mean if we get statistically significant improved (p<0.05) for Pain at WOMAC scores at day53 in PARA_008, no serious AEs, even though secondary endpoints not met, we will still get FDA approved?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
40.5¢
Change
-0.015(3.57%)
Mkt cap ! $160.9M
Open High Low Value Volume
41.5¢ 41.5¢ 40.0¢ $103.3K 254.3K

Buyers (Bids)

No. Vol. Price($)
8 47640 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 20243 4
View Market Depth
Last trade - 15.45pm 21/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.